Given identified epigenetic alterations on the C/EBP sites of genes of fatty liver, fibrosis and proliferation (Figure 4, Figure 5, Figure 6), it will be important to examine whether C/EBPα might also contribute to HFD during pregnancy associated-liver disorders in offspring. This evidence concerns the gene CEBPA and fatty liver disease.